Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03693404 · ClinicalTrials.gov registry record · Phase 4
Effects of a Surgical Site Injection on Pain Scores and Narcotic Use After Orthopaedic Trauma Surgery
A Phase 4 study, sponsored by NYU Langone Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 190
- Enrollment target
NCT03693404 is a Phase 4 study that has completed, run by NYU Langone Health. The registered enrollment target is 190 participants.
The verdict
NCT03693404, a Phase 4 study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 190 participants
- Enrollment target
Study Summary
This is a phase I, randomized, single-blind, placebo-controlled, single-center study of the effects of surgical site injection on pain and narcotic utilization in participants who undergo surgery for lower extremity fractures. 200 participants with lower extremity fractures who are admitted for operative fixation will be included in the study. Participants will be randomized to receive either a pain cocktail injection around the fracture site and surrounding tissues or control (no injection). An analysis of pain scores, rehabilitation progress, length of stay, narcotic utilization, and satisfaction scores will be performed.
Interventions
- DRUG Marcaine, Duramorph , ketorolac
- DRUG Bupivacaine (Marcaine)
- DRUG General Anesthetics
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2018-12-01 |
| Est. Completion | 2021-06-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03693404
The ClinicalTrials.gov registry entry for NCT03693404 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 190 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Marcaine, Duramorph , ketorolac is the first listed.
NCT03693404 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03693404 about?
NCT03693404 is a clinical study titled "Effects of a Surgical Site Injection on Pain Scores and Narcotic Use After Orthopaedic Trauma Surgery". This is a phase I, randomized, single-blind, placebo-controlled, single-center study of the effects of surgical site injection on pain and narcotic utilization in participants who undergo surgery for lower extremity fractures. 200 participants with lower extremity fractures who are admitted for oper...
What is the current status of trial NCT03693404?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 190 participants. The study started on 2018-12-01. Estimated completion is 2021-06-05.
What interventions are being tested in trial NCT03693404?
The interventions under investigation include: Marcaine, Duramorph , ketorolac (DRUG), Bupivacaine (Marcaine) (DRUG), General Anesthetics (DRUG).
Who is sponsoring clinical trial NCT03693404?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.